Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PB) Cash & Equivalents (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Cash & Equivalents for 13 consecutive years, with $9.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 33.29% year-over-year to $9.1 million, compared with a TTM value of $9.1 million through Dec 2025, up 33.29%, and an annual FY2025 reading of $9.1 million, up 33.29% over the prior year.
  • Cash & Equivalents was $9.1 million for Q4 2025 at Global Medical REIT, up from $7.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $9.1 million in Q4 2025 and bottomed at $1.3 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $4.8 million, with a median of $5.4 million recorded in 2021.
  • Peak annual rise in Cash & Equivalents hit 433.26% in 2024, while the deepest fall reached 71.04% in 2024.
  • Year by year, Cash & Equivalents stood at $7.2 million in 2021, then plummeted by 44.32% to $4.0 million in 2022, then tumbled by 68.18% to $1.3 million in 2023, then surged by 433.26% to $6.8 million in 2024, then surged by 33.29% to $9.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for GMRE-PB at $9.1 million in Q4 2025, $7.1 million in Q3 2025, and $6.6 million in Q2 2025.